Injectable PrEP Could Be Approved in 2022 (Cabotegravir)
1838
Bi-monthly injections of cabotegravir may soon be available as new pre-exposure prophylaxis (PrEP) HIV prevention option.
1838
Bi-monthly injections of cabotegravir may soon be available as new pre-exposure prophylaxis (PrEP) HIV prevention option.